bpc 157 not working BPC-157 vs. TB-500: What Patients Should Know The Benefits of BPC-157: A

Duration by study type Typical protocol durations: Acute injury (muscle, tendon, cardiac): 2-4 weeks Subacute research applications studies: 4-6 weeks Chronic remodelling or long-term studies: 6-12 weeks Research safety studies: 12+ weeks in extended protocols 7

These factors must be evaluated to ensure the safe and effective use of B12 injections

After the initial six weeks, the injections can be tapered down to being given less frequently, often once every one to two months

Human data on BPC-157 remains limited, and there have only been a handful of small, uncontrolled studies, none of them randomized

The peptide may also suit people who have tried semaglutide or other GLP-1 agonists and cannot tolerate the gastrointestinal side effects

Adverse events were reported in 10 patients, with six from the loading dose group and four from the no loading dose group